Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fluorescent Polysaccharide Nanogels for the Detection of Tumor Heterogeneity in Drug-Surviving Cancer Cells.

Advanced biosystems - 1 Feb 2020

Wang Chenglong, Wang Fanchen, Zhang Jinguo, Liu Lingshan, Xu Guoxiong, Dou Hongjing

Abstract excerpt

Tumor metastasis, recurrence, and drug resistance have been associated with tumor heterogeneity, and thus the identification of tumor heterogeneity has great significance in medicine. The approach provides a way to identify and isolate various cell subtypes from drug-surviving ovarian cancer cells, by synthesizing a series of polysaccharide nanogels and using them in flow cytometry analysis. The results show that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Movement

Share to Cell Survival

Share to Drug Resistance, Neoplasm

Share to Fluorescent Dyes

Share to Phenotype

Share to Polysaccharides

Source

Identifiers

PMID: 32293135
DOI: 10.1002/adbi.201900213

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fluorescent Polysaccharide Nanogels for the Detection of Tumor Heterogeneity in Drug-Surviving Cancer Cells.PMID 32293135Read ↗

Metronomic and single high-dose paclitaxel treatments produce distinct heterogenous chemoresistant cancer cell populationsSemantic proximity Read ↗

Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian CancersSemantic proximity Read ↗

Label-free microfluidic enrichment of cancer cells from non-cancer cells in ascites.Semantic proximity Read ↗

Phenotype-related drug sensitivity analysis of single CTCs for medicine evaluationSemantic proximity Read ↗

Sialic acid-binding lectin-modified fructose-coated nanoparticles: a promising targeted therapeutic synthetic for breast cancersSemantic proximity Read ↗

Stochastic phenotypic interconversion in tumors can generate heterogeneity.Semantic proximity Read ↗

Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveauSemantic proximity Read ↗

Enhancing Cancer Therapy through Polymeric Nano-particles: Targeted Drug Delivery StrategiesSemantic proximity Read ↗

Dynamic characterization of drug resistance and heterogeneity of the gastric cancer cell BGC823 using single-cell Raman spectroscopySemantic proximity Read ↗

Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against Glioblastoma and Pancreatic CancerSemantic proximity Read ↗

Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment.Semantic proximity Read ↗

Microparticle-associated nucleic acids mediate trait dominance in cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.